학술논문
Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer
Document Type
Article
Author
Source
In Heliyon 29 February 2024 10(4)
Subject
Language
ISSN
2405-8440